Alector (ALEC) Capital Expenditures Growth (1y) (2019 - 2026)
Powered by 
Analysis
Alector (ALEC) Capital Expenditures Growth (1y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 39.02% |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 30.84% |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | -22.99% |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 9.68% |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 1,133.33% |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 142.64% |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 53.76% |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | -73.62% |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | 210.00% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 210.00% |
| Mar 31, 2026 | 490.00% |
| Sep 30, 2025 | -94.81% |
| Jun 30, 2025 | -97.03% |
| Mar 31, 2025 | -96.25% |
| Dec 31, 2024 | -25.75% |
| Sep 30, 2024 | 325.53% |
| Jun 30, 2024 | -72.31% |
| Mar 31, 2024 | -48.00% |
| Dec 31, 2023 | -69.58% |
| Sep 30, 2023 | -104.91% |
| Jun 30, 2023 | 63.58% |
| Mar 31, 2023 | 48.12% |
| Dec 31, 2022 | 37.52% |
| Sep 30, 2022 | 109.29% |
| Jun 30, 2022 | -10.14% |
| Mar 31, 2022 | -26.93% |
| Dec 31, 2021 | -29.31% |
| Sep 30, 2021 | 140.16% |
| Jun 30, 2021 | 178.79% |